156 related articles for article (PubMed ID: 37322265)
1. The Role of Preoperative Inflammatory Markers in Pancreatectomy: a Norwegian Nationwide Cohort Study.
Sahakyan MA; Kleive D; Dille-Amdam RG; Kjeseth T; Waardal K; Edwin B; Nymo LS; Lassen K
J Gastrointest Surg; 2023 Aug; 27(8):1650-1659. PubMed ID: 37322265
[TBL] [Abstract][Full Text] [Related]
2. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.
Ikuta S; Aihara T; Yamanaka N
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282
[TBL] [Abstract][Full Text] [Related]
3. DUPAN-2 as a Risk Factor of Early Recurrence After Curative Pancreatectomy for Patients With Pancreatic Ductal Adenocarcinoma.
Sasaki A; Sakata K; Nakano K; Tsutsumi S; Fujishima H; Futsukaichi T; Terashi T; Ikebe M; Bandoh T; Utsunomiya T
Pancreas; 2023 Feb; 52(2):e110-e114. PubMed ID: 37523601
[TBL] [Abstract][Full Text] [Related]
4. The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic cancer resection.
van Wijk L; de Klein GW; Kanters MA; Patijn GA; Klaase JM
Eur J Med Res; 2020 Oct; 25(1):46. PubMed ID: 33028394
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma.
Arima K; Yamashita YI; Hashimoto D; Nakagawa S; Umezaki N; Yamao T; Tsukamoto M; Kitano Y; Yamamura K; Miyata T; Okabe H; Ishimoto T; Imai K; Chikamoto A; Baba H
Am J Surg; 2018 Jul; 216(1):111-115. PubMed ID: 28859917
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Inflammatory Markers in Liver Resection for Colorectal Liver Metastases: A National Registry-Based Study.
Sahakyan MA; Brudvik KW; Angelsen JH; Dille-Amdam RG; Sandvik OM; Edwin B; Nymo LS; Lassen K
World J Surg; 2023 Sep; 47(9):2213-2220. PubMed ID: 37140610
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.
Murakawa M; Yamamoto N; Kamioka Y; Kamiya M; Kobayashi S; Ueno M; Morimoto M; Atsumi Y; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
In Vivo; 2020; 34(1):347-353. PubMed ID: 31882498
[TBL] [Abstract][Full Text] [Related]
8. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
10. Strategy of Pancreatectomies for Pancreatic Ductal Adenocarcinoma in Patients with a History of Gastrectomy.
Amikura K; Ogura T; Takahashi A
Tohoku J Exp Med; 2022 Apr; 256(4):337-348. PubMed ID: 35321979
[TBL] [Abstract][Full Text] [Related]
11. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
[TBL] [Abstract][Full Text] [Related]
12. What is the impact of zinc deficiency for pancreatectomies in patients with pancreatic ductal adenocarcinoma?
Iseki M; Mizuma M; Aoki S; Kawaguchi K; Masuda K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
Pancreatology; 2022 Mar; 22(2):270-276. PubMed ID: 35012903
[TBL] [Abstract][Full Text] [Related]
13. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.
Miura T; Hirano S; Nakamura T; Tanaka E; Shichinohe T; Tsuchikawa T; Kato K; Matsumoto J; Kondo S
Surgery; 2014 Mar; 155(3):457-67. PubMed ID: 24462074
[TBL] [Abstract][Full Text] [Related]
14. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
[TBL] [Abstract][Full Text] [Related]
15. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma.
Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Updates Surg; 2021 Feb; 73(1):251-259. PubMed ID: 32410163
[TBL] [Abstract][Full Text] [Related]
16. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
[TBL] [Abstract][Full Text] [Related]
17. Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma.
Yamada S; Shimada M; Morine Y; Imura S; Ikemoto T; Saito Y; Miyazaki K; Tokunaga T; Nishi M
World J Surg Oncol; 2021 Mar; 19(1):94. PubMed ID: 33781262
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Patients With Stage II to III Colorectal Cancer.
Ahiko Y; Shida D; Nakamura Y; Imaizumi J; Takamizawa Y; Moritani K; Tsukamoto S; Kanemitsu Y
Dis Colon Rectum; 2021 Oct; 64(10):1222-1231. PubMed ID: 33951689
[TBL] [Abstract][Full Text] [Related]
19. Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer.
Oshima M; Okano K; Suto H; Ando Y; Kamada H; Masaki T; Takahashi S; Shibata T; Suzuki Y
BMC Gastroenterol; 2020 Dec; 20(1):423. PubMed ID: 33317455
[TBL] [Abstract][Full Text] [Related]
20. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
